{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:51Z","timestamp":1790386671600,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227077","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T18:26:21Z","timestamp":1578939981000},"page":"e0227077","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Characterization of the visceral and neuronal phenotype of 4L\/PS-NA mice modeling Gaucher disease"],"prefix":"10.1371","volume":"15","author":[{"given":"Victoria","family":"Schiffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Santiago-Mujika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-3907","authenticated-orcid":true,"given":"Stefanie","family":"Flunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Farcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Schilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Posch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Neddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Hutter-Paier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"issue":"17","key":"pone.0227077.ref001","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"E Sidransky","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"5","key":"pone.0227077.ref002","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders","volume":"120","author":"O Goker-Alpan","year":"2010","journal-title":"Acta neuropathologica"},{"issue":"2","key":"pone.0227077.ref003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments","volume":"18","author":"J Stirnemann","year":"2017","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"pone.0227077.ref004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","article-title":"The clinical management of Type 2 Gaucher disease","volume":"114","author":"K Weiss","year":"2015","journal-title":"Molecular genetics and metabolism"},{"issue":"4","key":"pone.0227077.ref005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1096-7192(02)00114-2","article-title":"Prosaposin: threshold rescue and analysis of the \"neuritogenic\" region in transgenic mice","volume":"76","author":"Y Sun","year":"2002","journal-title":"Molecular genetics and metabolism"},{"issue":"6","key":"pone.0227077.ref006","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/hmg\/5.6.711","article-title":"Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids","volume":"5","author":"N Fujita","year":"1996","journal-title":"Human molecular genetics"},{"issue":"6377","key":"pone.0227077.ref007","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"VL Tybulewicz","year":"1992","journal-title":"Nature"},{"issue":"4","key":"pone.0227077.ref008","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1203\/00006450-199210000-00023","article-title":"Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene","volume":"32","author":"E Sidransky","year":"1992","journal-title":"Pediatric research"},{"issue":"5","key":"pone.0227077.ref009","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Y Liu","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"pone.0227077.ref010","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"YH Xu","year":"2003","journal-title":"The American journal of pathology"},{"issue":"10","key":"pone.0227077.ref011","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Y Sun","year":"2005","journal-title":"Journal of lipid research"},{"issue":"11","key":"pone.0227077.ref012","doi-asserted-by":"crossref","first-page":"e79732","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"A Rolfs","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"pone.0227077.ref013","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"YH Xu","year":"2011","journal-title":"Molecular genetics and metabolism"},{"key":"pone.0227077.ref014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneumeth.2016.10.006","article-title":"Quantitative evaluation of orofacial motor function in mice: The pasta gnawing test, a voluntary and stress-free behavior test","volume":"274","author":"R Rabl","year":"2016","journal-title":"Journal of neuroscience methods"},{"issue":"1","key":"pone.0227077.ref015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12868-017-0341-8","article-title":"Early start of progressive motor deficits in Line 61 alpha-synuclein transgenic mice","volume":"18","author":"R Rabl","year":"2017","journal-title":"BMC neuroscience"},{"issue":"3","key":"pone.0227077.ref016","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"K Wong","year":"2004","journal-title":"Molecular genetics and metabolism"},{"issue":"1","key":"pone.0227077.ref017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0028-1091508","article-title":"Infantile Gaucher's disease: neuropathology, acid hydrolase activities and negative staining observations","volume":"8","author":"MA Verity","year":"1977","journal-title":"Neuropadiatrie"},{"issue":"15","key":"pone.0227077.ref018","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/hmg\/ddu105","article-title":"Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice","volume":"23","author":"YH Xu","year":"2014","journal-title":"Human molecular genetics"},{"issue":"1\u20132","key":"pone.0227077.ref019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2011.06.008","article-title":"Aggregation of alpha-synuclein in brain samples from subjects with glucocerebrosidase mutations","volume":"104","author":"JH Choi","year":"2011","journal-title":"Molecular genetics and metabolism"},{"issue":"1","key":"pone.0227077.ref020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"JR Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"3","key":"pone.0227077.ref021","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1212\/NXG.0000000000000158","article-title":"Previously unrecognized behavioral phenotype in Gaucher disease type 3","volume":"3","author":"M Abdelwahab","year":"2017","journal-title":"Neurology Genetics"},{"issue":"4","key":"pone.0227077.ref022","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry","volume":"33","author":"A Tylki-Szymanska","year":"2010","journal-title":"Journal of inherited metabolic disease"},{"issue":"4","key":"pone.0227077.ref023","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"A Tajima","year":"2009","journal-title":"Molecular genetics and metabolism"},{"issue":"1","key":"pone.0227077.ref024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/JPD-150660","article-title":"Impaired gait kinematics in type 1 Gaucher's Disease","volume":"6","author":"P Sorrentino","year":"2016","journal-title":"Journal of Parkinson's disease"},{"issue":"2","key":"pone.0227077.ref025","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1212\/NXG.0000000000000055","article-title":"Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in Egypt","volume":"2","author":"M Abdelwahab","year":"2016","journal-title":"Neurology Genetics"},{"issue":"18","key":"pone.0227077.ref026","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"J Charrow","year":"2000","journal-title":"Archives of internal medicine"},{"issue":"6","key":"pone.0227077.ref027","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0046-8177(99)90092-8","article-title":"Pulmonary pathology in Gaucher's disease","volume":"30","author":"G Amir","year":"1999","journal-title":"Hum Pathol"},{"issue":"2","key":"pone.0227077.ref028","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/rg.262045213","article-title":"he thymus: a comprehensive review","volume":"26","author":"M Nishino","year":"2006","journal-title":"TRadiographics: a review publication of the Radiological Society of North America, Inc"},{"issue":"6","key":"pone.0227077.ref029","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Y Sun","year":"2010","journal-title":"Human molecular genetics"},{"issue":"16","key":"pone.0227077.ref030","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1021\/acs.analchem.7b01442","article-title":"Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease","volume":"89","author":"R Hamler","year":"2017","journal-title":"Analytical chemistry"},{"issue":"10","key":"pone.0227077.ref031","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1177\/2472555217719372","article-title":"Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS\/MS and High-Resolution MALDI Imaging Mass Spectrometry","volume":"22","author":"EE Jones","year":"2017","journal-title":"SLAS discovery: advancing life sciences R & D"},{"key":"pone.0227077.ref032","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2015.07.026","article-title":"Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool","volume":"450","author":"M Fuller","year":"2015","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"11","key":"pone.0227077.ref033","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"V Murugesan","year":"2016","journal-title":"American journal of hematology"},{"issue":"2","key":"pone.0227077.ref034","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2014.08.011","article-title":"CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings","volume":"114","author":"TA Burrow","year":"2015","journal-title":"Molecular genetics and metabolism"},{"issue":"Pt 6","key":"pone.0227077.ref035","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease","volume":"135","author":"EB Vitner","year":"2012","journal-title":"Brain: a journal of neurology"},{"issue":"7","key":"pone.0227077.ref036","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","article-title":"Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease","volume":"20","author":"T Farfel-Becker","year":"2011","journal-title":"Human molecular genetics"},{"issue":"2","key":"pone.0227077.ref037","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2013.12.003","article-title":"Neuroinflammation and alpha-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction","volume":"111","author":"EI Ginns","year":"2014","journal-title":"Molecular genetics and metabolism"},{"key":"pone.0227077.ref038","doi-asserted-by":"crossref","first-page":"212 e5","DOI":"10.1016\/j.neurobiolaging.2016.04.022","article-title":"Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden","volume":"45","author":"C Ran","year":"2016","journal-title":"Neurobiology of aging"},{"issue":"6","key":"pone.0227077.ref039","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10571-015-0176-8","article-title":"Gaucher-Associated Parkinsonism","volume":"35","author":"Y Li","year":"2015","journal-title":"Cellular and molecular neurobiology"},{"issue":"7","key":"pone.0227077.ref040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2174\/1389203717666160311115956","article-title":"Involvement of Gaucher Disease Mutations in Parkinson Disease","volume":"18","author":"L Vilageliu","year":"2017","journal-title":"Curr Protein Pept Sci"},{"key":"pone.0227077.ref041","article-title":"The effect of mutant GBA1 on accumulation and aggregation of alpha-synuclein","author":"G Maor","year":"2019","journal-title":"Human molecular genetics"},{"issue":"40","key":"pone.0227077.ref042","first-page":"9617","article-title":"Glucosylsphingosine Promotes alpha-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease. The Journal of neuroscience: the official journal of the","volume":"37","author":"YV Taguchi","year":"2017","journal-title":"Society for Neuroscience"},{"issue":"6","key":"pone.0227077.ref043","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"V Cullen","year":"2011","journal-title":"Annals of neurology"},{"issue":"1","key":"pone.0227077.ref044","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004010050960","article-title":"Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant","volume":"97","author":"T Pampols","year":"1999","journal-title":"Acta neuropathologica"},{"issue":"2","key":"pone.0227077.ref045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF00293959","article-title":"Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings","volume":"82","author":"N Conradi","year":"1991","journal-title":"Acta neuropathologica"},{"issue":"10","key":"pone.0227077.ref046","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/jnr.22371","article-title":"A mutation in the saposin C domain of the sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice","volume":"88","author":"A Yoneshige","year":"2010","journal-title":"Journal of neuroscience research"},{"issue":"4","key":"pone.0227077.ref047","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/hmg\/ddp531","article-title":"Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse","volume":"19","author":"Y Sun","year":"2010","journal-title":"Human molecular genetics"},{"issue":"9","key":"pone.0227077.ref048","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"H Mizukami","year":"2002","journal-title":"The Journal of clinical investigation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T01:42:18Z","timestamp":1665452538000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227077"}},"subtitle":[],"editor":[{"given":"Israel","family":"Silman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227077","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]}}}